Stephen Ubl
Stephen Ubl is the CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), an influential industry lobby group. He is noted for his advocacy for the pharmaceutical industry and has expressed eagerness to collaborate with the Trump administration to improve health outcomes and make healthcare more affordable for Americans, particularly following the confirmation of Robert F Kennedy Jr. as Secretary of Health.
Not in the pool (under ¢1).
Recent news mentions
President Stephen Ubl of PhRMA has come out strongly against the pricing policy, arguing that the problem isn’t high U.S. prices, but low prices elsewhere.
Potential U.S. tariffs, pricing rules raise uncertainty in drug industry
Canada· 2025-07-11
Stephen Ubl, CEO of industry trade group PhRMA, said in a statement that importing foreign prices from socialist countries would be a bad deal for American patients and workers.
Trump executive order demands pharma industry price cuts
Guyana· 2025-05-13
PhRMA CEO Stephen Ubl said in a statement that importing foreign prices from socialist countries would be a bad deal for American patients and workers.
Trump signs executive order to demand pharma industry cuts pricesGuyana· 2025-05-12The president of the Pharmaceutical Research and Manufacturers of America, Stephen Ubl, opposed the executive order.
Trump signs executive order aimed at lowering drug prices for Americans
United States· 2025-05-12
Stephen Ubl, CEO of Pharmaceutical Research and Manufacturers of America, expressed eagerness to work with the Trump administration.
US Senate confirms Robert F Kennedy jnr as secretary of health – The Irish Times
Ireland· 2025-02-13
